Publications by authors named "F Berteau"
Background: Response to prophylactic platelet transfusion is suspected to be inconsistent in critically ill patients questioning how to optimize transfusion practices. This study aimed to describe prophylactic platelet transfusion response, to identify factors associated with a suboptimal response, to analyse the correlation between corrected count increment and platelet count increment and to determine the association between poor platelet transfusion response and clinical outcomes.
Methods: This prospective multicentre observational study recruited patients who received at least one prophylactic platelet transfusion in one of the nine participating intensive care units for a period up to 16 months.
Objective: Pneumonia is the most frequent infectious complication in patients who have experienced drowning that requires intensive care unit (ICU) admission. We aimed to describe clinical, microbiological, and therapeutic data as well as predictors and impacts of such pneumonia on patients' outcomes.
Methods: We conducted a retrospective, multicentre study (2013-2020) of 270 consecutive patients admitted for drowning to 14 ICUs in Western France.
Background: Drowning is a global threat and one of the leading causes of injury around the world. The impact of drowning conditions including water salinity on patients' prognosis remains poorly explored in Intensive Care Units (ICUs) patients.
Methods: We conducted a retrospective multicenter study on patients admitted to 14 ICUs in the west of France from January 2013 to January 2020.
Article Synopsis
- The study aimed to create a murine model to examine how complex antibiotics like ceftriaxone and cefotaxime affect gut bacteria and the presence of extended-spectrum beta-lactamase (ESBL) producing bacteria.
- Mice treated with ceftriaxone showed higher colonization of ESBL-producing bacteria compared to those treated with cefotaxime, indicating different impacts on gut microbiota composition.
- The research concluded that substituting ceftriaxone with cefotaxime could help in preventing the selection of harmful ESBL-producing bacteria due to the distinct microbial communities shaped by each antibiotic.